Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct 28;18(20):1581-6.
doi: 10.1016/j.cub.2008.08.070.

Actin dynamics is essential for myosin-based transport of membrane organelles

Affiliations

Actin dynamics is essential for myosin-based transport of membrane organelles

Irina Semenova et al. Curr Biol. .

Abstract

Actin filaments that serve as "rails" for the myosin-based transport of membrane organelles [1-4] continuously turn over by concurrent growth and shortening at the opposite ends [5]. Although it is known that dynamics of actin filaments is essential for many of the actin cytoskeleton functions, the role of such dynamics in myosin-mediated organelle transport was never studied before. Here, we addressed the role of turnover of actin filaments in the myosin-based transport of membrane organelles by treating cells with the drugs that suppress actin-filament dynamics and found that such a suppression significantly inhibited organelle transport along the actin filaments without inhibiting their intracellular distribution or the activity of the myosin motors. We conclude that dynamics of actin filaments is essential for myosin-based transport of membrane organelles and suggest a previously unknown role of actin-filament dynamics in providing the "rails" for continuous organelle movement resulting in the increased distances traveled by membrane organelles along the actin filaments.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Treatment of melanophores with actin filament-stabilizing drugs inhibits transport of pigment granules
A, Phase contrast images of melanophores treated with melatonin to induce pigment aggregation (top row), or with melanocyte-stimulating hormone to induce pigment dispersion (bottom row) in the absence (left panel) or in the presence (right panel) of jasplakinolide (1 μM); pairs of images in each panel show the same cells before or 10 min after hormone treatment; while pigment aggregation occurred with a normal kinetics, the rate of pigment dispersion was significantly inhibited in jasplakinolide-treated cells; numbers indicate time in min; bar, 20 μm. B, Quantification of actin-dependent movement of pigment granules measured in cells with disrupted cytoplasmic microtubules; plots show changes with time of averaged squared distances traveled by pigment granules from a starting point in control cells (black squares), cells treated with jasplakinolilde (1 μM) for 5 min (red circles), cells injected with phalloidin solution (100 μM; purple triangles), buffer-injected cells (blue diamonds), GFP-overexpressing cells (green triangles), or cells overexpressing dominant-negative myosin Va construct (MST-GFP; dark blue triangles); treatment of cells with jasplakinolide or microinjection with phalloidin solution reduces the movement of pigment granules to the levels seen in melanophores overexpressing dominant-negative myosin Va. C, Decomposition of the trajectories of pigment granule movement in cells with disrupted microtubules into linear (blue) and random diffusion-like displacements (green) using multiscale trend analysis in control (two top trajectories) and jasplakinolide-treated (two bottom trajectories) cells; the lengths of linear segments of the trajectories that likely correspond to actin-based runs are significantly shorter in jasplakinolide-treated cells. See also Supplemental Videos 1-6.
Figure 2
Figure 2. Jasplakinolide treatment stabilizes actin filaments, but does not significantly change their organization, or the levels of actin polymer in the cytoplasm
A and B, FRAP analysis of the turnover rates of actin filaments in control and jasplakinolide-treated cells. A, Sets of successive images of the bleached zones in control non-treated (left) or jasplakinolide-treated (right) cells; bar, 10 μm. B, Quantification of fluorescence recovery in the bleached zones located at approximately equal distances from the cell center and cell margin in the areas of the cytoplasm capable for supporting actin-based transport; black squares, control cells; gray circles, jasplakinolide-treated cells; error bars represent SEM for measurements in ten different cells; recovery of actin fluorescence is significantly faster in control than in jasplakinolide-treated cells; numbers shown on panel A indicate time after the photobleaching. C, Distribution of actin fluorescence in the same cell before (middle) or 5 min after (right) application of jasplakinolide; for the labeling of actin filaments, the cell was injected with rhodamine-actin 2 hours prior to acquisition of images; left, phase contrast image that shows distribution of pigment granules in the same cell; jasplakinolide treatment does not significantly change the distribution of actin fluorescence; bar, 20 μm. D, Electron micrographs of platinum replicas of cytoplasmic regions located at approximately equal distances from the cell center and cell margin in control non-treated (left) and a jasplakinolide-treated (right) melanophore; characteristic rope-like appearance of the actin filaments (inserts), which allowed their identification in electron micrographs, is explained by their decoration with the S1 subfragment of myosin during the preparation of samples for electron microscopy [7]; the S1-decorated actin filaments are highlighted in yellow; jasplakinolide treatment did not significantly change actin filament distribution; bar, 0.5 μm. E, Quantification of the actin filament density by measuring length of actin filaments in electron micrographs of control non-treated and jasplakinolide-treated cells; error bars represent SEM for measurements in ten different cells; jasplakinolide treatment does not significantly the density of actin filaments. See also Supplemental Videos 7-8.
Figure 3
Figure 3. Jasplakinolide does not affect myosin-driven movement of isolated pigment granules along actin filaments examined in in vitro motility assay
A, Successive images of fluorescently labeled actin filaments and pigment granules acquired in the absence (top panel) or in the presence (bottom panel) of jasplakinolide (1 μM); in both control and jasplakinolide-containing samples pigment granules often attached to actin filaments and moved along them, which indicates that jasplakinolide does not significantly inhibit myosin-based transport of pigment granules; numbers indicate time in s; bar, 0.5 μm. B, Frequency histograms of movement velocities of pigment granules along the actin filaments in vitro in the absence (left) or presence (right) of jasplakinolide; in both the presence or the absence of jasplakinolide the movement velocities peaked at about 3 μm/min, which indicates that the drug has no detectable effect on the activity of myosin Va. See also Supplemental Videos 9-10.
Figure 4
Figure 4. Role of actin dynamics in the myosin-based transport of pigment granules
Myosin Va moves pigment granule towards the plus ends of actin filaments, which grow at the same time. Therefore growth of actin filaments should increase distance traveled by pigment granule along them.

Comment in

Similar articles

Cited by

References

    1. Berg JS, Powell BC, Cheney RE. A millennial myosin census. Mol Biol Cell. 2001;12:780–794. - PMC - PubMed
    1. Krendel M, Mooseker MS. Myosins: tails (and heads) of functional diversity. Physiology (Bethesda) 2005;20:239–251. - PubMed
    1. Mooseker MS, Cheney RE. Unconventional myosins. Annu Rev Cell Dev Biol. 1995;11:633–675. - PubMed
    1. Tuxworth RI, Titus MA. Unconventional myosins: anchors in the membrane traffic relay. Traffic. 2000;1:11–18. - PubMed
    1. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003;112:453–465. - PubMed

Publication types

LinkOut - more resources